Document is current
Any future updates will be listed below
-
Authors
Wang, Chunlin
Zhu, Dake
Sansone, Andrea https://orcid.org/0000-0002-1210-2843
Colonnello, Elena https://orcid.org/0000-0002-0081-7163
Limoncin, Erika https://orcid.org/0009-0001-5094-0688
Mollaioli, Daniele
Zhang, Yan https://orcid.org/0000-0003-4119-7359
Jannini, Emmanuele A. https://orcid.org/0000-0002-5874-039X
- License Information
-
More Information
Article History
Received: 7 June 2025
Revised: 6 November 2025
Accepted: 27 January 2026
First Online: 25 February 2026
Competing interests
: EAJ is or has been a consultant and/or paid speaker for Bayer, FQM, Ibsa, Kanna, Lundbeck, Menarini, Merck, Mia, Otsuka, Pfizer, Recordati, Shionogi, and Viatris. The other authors declare no competing interests.
: The protocol approval was obtained from the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University (II2024-064-01).
: All methods in this study were performed in accordance with the Declaration of Helsinki and relevant national and institutional guidelines and regulations. The study protocol was reviewed and approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China (approval number: II2024-064-01). Written informed consent was obtained from all participants prior to their inclusion in the study. No identifiable images or personal data of human participants are included in this article; therefore, consent for publication of images was not applicable.
